-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Immunovant, Inc. quarterly/annual Return On Equity history and growth rate from 2019 to 2023.
- Immunovant, Inc. Return On Equity for the quarter ending March 31, 2024 was -56.1 %, a 7.02% decline year-over-year.
- Immunovant, Inc. annual Return On Equity for 2023 was -64.5 %, a 43.4% decline from 2022.
- Immunovant, Inc. annual Return On Equity for 2022 was -45 %, a 8.42% decline from 2021.
- Immunovant, Inc. annual Return On Equity for 2021 was -41.5 %, a 83.5% increase from 2020.
Return On Equity, Annual (% [USD])
Return On Equity, YoY Annual Growth (%)